BioSpace News Archive

Todos Medical Ltd. announced that it has rapidly expanded its agreement with a Wisconsin-based laboratory to supply it with the necessary testing equipment and supplies to ramp up to 12,000 tests a day, for a total contract value of $47.5 million in reagent sales by Todos Medical over the next seven months.

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that the company has received a new funding grant to advance its research program for Charcot-Marie Tooth (CMT), a genetically-driven, rare neuromuscular disease.

Medigate, the leader in IoT and medical device security and asset management, today announced that it has entered into an agreement with Arrow Electronics, Inc. to bring healthcare delivery organizations (HDOs) award-winning cybersecurity solutions for their connected devices.

Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s anti-PD-1 drug candidate, in endometrial cancer.

The Physicians Committee for Responsible Medicine filed a lawsuit on Sept. 22 against the Food and Drug Administration (FDA) for failing to respond to a petition that asks the agency to require cheese manufacturers to add the following warning label on all dairy cheese products: “Dairy cheese contains reproductive hormones that may increase breast cancer mortality risk.” The petition, which was filed on Oct. 3, 2019, ci

Adial Pharmaceuticals, Inc.today announced that the two companies have commenced sales of FaStep COVID-19 IgG/IgM rapid antibody test kits to healthcare providers and hospitals through the iRemedy network and ecommerce platform.

- BioTheryX, Inc., a clinical stage biotechnology company harnessing the power of protein modulation to treat difficult diseases, today announced that Frank Mercurio , Ph.D., Chief Scientific Officer of BioTheryX, will be presenting at two upcoming industry conferences:

Bosma Enterprises and the Wounded Warrior Program are excited to announce a strategic partnership to generate opportunities and employment for people with vision loss and wounded veterans.

Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials to test a medical hypothesis that has been advanced over the last five years that Parkinson’s disease may be caused by vascular disruption in the areas of the brain which house the “dopamine-producing neurons”, those neurons which become dysfunctional in patients suffering from this disorder. The hypothesis is simply that the micro-vascula

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced approval from the Brazilian Health Regulatory Agency (ANVISA) for its ongoing global Phase 2/3 study evaluating opaganib1 in patients hospitalized with severe COVID-19 pneumonia.